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ABSTRACT 
Urinary tract infections (UTIs) are one of the most common bacterial infections in humans. 
Current knowledge on antimicrobial susceptibility pattern is essential for appropriate therapy. 
Therefore the aim of the present study was to determine the distribution and antibiotic suscep-
tibility pattern of bacterial strains, with special reference to ESBL, AmpC β-lactamase and 
MRSA production.  A total of 325 clinical isolates were collected from UTI patients from var-
ious tertiary care hospitals over a period of 6 months (June 2011 to December 2011). The an-
timicrobial susceptibility to various drugs was studied by the disc diffusion method as guided 
by CLSI guidelines. Confirmation of the extended spectrum β-lactamase (ESBL), AmpC β-
lactamase and methicillin resistant Staphylococcus aureus (MRSA) production was done by 
an E-test respectively. Of the 325 isolates, 225 were characterized as gram negative and 
77 isolates as S. aureus isolates. The majority (69.3 %) of the isolates were from females 
compared to males (30.7 %). Prevalence of ESBL and AmpC β-lactamase and the coexistence 
of the phenotype (ESBL+ AmpC β-lactamase) and MRSA in the urinary isolates were found 
to be 48.9 %, 20.4 %, 6.2 % and 27.5 % respectively. Ampicillin/sulbactam, norfloxacin 
should be no longer considered as first line of drugs for UTI, because of high resistance. 
Parentral drugs such as aminoglycosides, carbapenems and piperacillin/tazobactum can be the 
alternative choice for complicated UTI. Also, control measures such as judicious use of anti-
biotics, formulation of infection committee may control the spread of resistance. 
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INTRODUCTION 
Urinary tract infections (UTIs) are 
among the most common bacterial infec-
tions both in the community and hospital 
setting (Mohammadi et al., 2010). UTI has 
become the most common hospital-
acquired infection, accounting for as many 
as 35 % of nosocomial infections (Ko-
lawole et al., 2009). UTI is the second most 
common infectious presentation in commu-
nity practice. It accounts for approximately 
one million hospitalizations annually 
worldwide (Farrell et al., 2003). It presents 
a spectrum of clinical entities upon severity 
ranging from asymptomatic infection to 
acute pyelonephritis with sepsis (Fish, 
2009). 
In the last few decades there have been 
significant changes in the antimicrobial re-
sistance patterns of uropathogens and re-
ports on spread of bacterial resistance 
among uropathogens (Mohammed et al., 
2007). The increasing prevalence of infec-
tions caused by antibiotic-resistant bacteria 
makes empirical treatment of these infec-
tions difficult (Steinke et al., 2001). The 
emergence of antibiotic resistance in the 
management of UTI infection is a serious 
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public health issue, particularly in the de-
veloping countries where apart from high 
level of poverty, ignorance and poor hy-
gienic practices, there is also high preva-
lence of fake and spurious drugs of ques-
tionable quality in circulation.  
In the majority of cases, antibiotics are 
given empirically before the final bacteriol-
ogy results are available. Antibiotic re-
sistance varies according to geographic lo-
cations and is directly proportional to the 
use and misuse of antibiotics. The re-
sistance pattern of community acquired UTI 
pathogens has not been studied extensively 
(Goldstein, 2000). The etiology of UTI and 
the antibiotic resistance of uropathogens 
have been changing over the past years, 
both in community and nosocomial infec-
tion (Manges et al., 2006). However, there 
is not much information available on etiol-
ogy and resistance pattern of community 
acquired UTIs in India. Consequently, area-
specific monitoring studies to document the 
microorganisms causing UTIs and their an-
timicrobial susceptibility is mandatory for 
helping the selection of an effective empiri-
cal treatment (Smith and Coast, 2002).  
Therefore, the present study was aimed at 
gaining knowledge about the type of patho-
gens responsible for and their susceptibility 
patterns which will help the clinicians to 
choose the right empirical treatment. 
 
MATERIALS AND METHODS 
Bacterial isolates 
A total of 325 consecutive, non-
repetitive, clinical isolates were collected 
from UTI patients from tertiary care hospi-
tals during 2011 (June to December) were 
included in the study. Urine samples were 
cultured using a 0.001 ml calibrated loop 
onto blood agar and MacConkey agar 
plates, incubated at 37 °C for 18-24 hours 
and the number of colonies was counted. 
Significant bacteriuria was defined as 
greater than 105 colony forming units/ml of 
a single pathogen. Isolates were identified 
based by standard microbiological proce-
dures (Koneman et al., 2006a, b). 
 
Antibiotic susceptibility testing 
The isolates were tested for their anti-
microbial susceptibility and the results were 
interpreted according to the guidelines of 
Clinical and Laboratory Standards Institute 
(CLSI, 2010). Gram negative isolates were 
tested against ampicillin (10 μg), ampicil-
lin/Sulbactam (20 µg/10 μg), piperacillin 
(100 µg); piperacillin-tazobactam 
(100 µg/10 μg), cephotaxime (30 μg), 
ceftriaxone (30 μg), ceftazidime (30 μg), 
cefoxitin (30 µg), amikacin (30 μg), nor-
floxacin (5 μg), nalidixic acid (30 μg), ni-
trofurantoin (300 μg), gentamicin (15 μg), 
ciprofloxacin (5 μg), trimethoprim-
sulfamethoxazole (1.25/23.75 μg), and 
imipenem (10 μg). S. aureus isolates were 
tested with oxacillin (1 µg); cefoxitin 
(30 µg); erythromycin (15 μg); mupirocin 
(5 μg); fusidic acid (30 μg); pristinomycin 
(15 μg); linezolid (30 μg); vancomycin 
(30 μg); teicoplanin (30 μg); rifampin 
(5 μg); chloramphenicol (30 μg); cotrimox-
azole (30 μg); ciprofloxacin (5 μg); gen-
tamicin (30 μg); amikacin (30 μg), and tet-
racycline (30 μg) (Hi Media, India). Multi-
drug resistance was defined as resistance to 
three or more different antimicrobial 
agents. E. coli ATCC 25922 and S. aureus 
ATCC 25923 was used as a quality control 
strain. 
 
Detection of ESBL 
According to the CLSI guidelines 
(CLSI 2010), isolates showing inhibition 
zone size of ≤ 22 mm with ceftazidime 
(30 μg), ≤ 25 mm with ceftriaxone (30 μg), 
and ≤ 27 mm with cefotaxime (30 μg) were 
interpreted as positive for ESBL production 
and shortlisted for confirmation of ESBL 
production. E. coli ATCC 25922 was used 
as the control strain. 
 
Confirmation of ESBL production by  
E-test 
Confirmation of ESBL was also done 
by E-test ESBL strips (Hi Media, India), 
and the test was performed in accordance 
with the manufacturer’s guidelines. Double 
ended strips containing gradient of cefotax-
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ime or ceftazidime at one end and cefotax-
ime or ceftazidime plus clavulanic acid at 
the other end were tested. The presence of 
ESBL was confirmed if the ratio of the 
MIC of cefotaxime or ceftazidime to the 
MIC of cefotaxime or ceftazidime plus 
clavulanic acid was ≥ 8 (CLSI, 2011).  
 
Phenotypic AmpC detection 
Since there are no published CLSI crite-
ria for phenotypic screening or confirmato-
ry test for AmpC β-lactamases, a modified 
three dimensional test was used for the de-
tection of AmpC enzymes in cefoxitin re-
sistant isolates (Singhal et al., 2005). 
 
Oxacillin E-test 
MICs of oxacillin were determined by 
the E-test (Hi Media, India) according to 
the instructions of the manufacturer. The 
plates were inoculated by swabbing the sur-
faces with a 0.5 McFarland’s standard bac-
terial suspension on the MHA medium 
which was supplemented with 2 % NaCl. 
The E-test strips were placed on the medi-
um, and the plates were then incubated at 
35 °C for 24 hours. The results were ana-
lyzed on the basis of the CLSI guidelines 
(CLSI, 2010).  
 
Statistical analysis 
Statistical package for social sciences 
(SPSS) version 18 was used to analyze our 
data. Clinical outcomes were compared sta-
tistically using Student’s t- test. P <0.05 
was taken as “statistically significant”.  
 
RESULTS 
During the study period, a total of 325 
isolates were collected from various 
healthcare centers, out of which 225 iso-
lates were characterized as gram negative 
and 77 isolates as S. aureus isolates. These 
isolates were identified up to species level 
by conventional methods. The uropatho-
gens isolates include Escherichia coli (91), 
Klebsiella pneumoniae (82), Pseudomonas 
aeruginosa (26), Proteus mirabilis (21), 
Enterobacter aerogenes (4), Citrobacter 
freundii (1) and Staphylococcus aureus 
(77). The number of uropathogens was 
larger in females (69.3 %) than in males 
(30.7 %). The difference was statistically 
significant (p<0.0001). Antibiogram pat-
terns of 225 gram negative isolates revealed 
that 78.7 % (177/225) isolates were found 
to be resistant to more than 3 antibiotics.  
By the screening test ESBL production 
was noticed in 145 (64.4 %) isolates with 
maximal incidence in E. coli (71.42 %) fol-
lowed by K. pneumoniae (65.9 %), P. aeru-
ginosa (50 %), Proteus mirabilis (47.61 %) 
and Enterobacter aerogenes (75 %). ESBL 
production was not noticed in Citrobacter 
freundii. Of the 145 ESBL screen positive 
isolates, 110 isolates were found to be 
ESBL producers by MIC using the E-test 
strip. MIC values of ESBL positive isolates 
towards cefotaxime alone were ≥ 64 µg/ml 
and for cefotaxime/clavulanate combination 
was ≥ 1 µg/ml.  
Overall, the prevalence of ESBL and 
AmpC β-lactamase and the coexistence of 
the phenotype (ESBL+ AmpC β-lactamase) 
and MRSA in the urinary isolates were 
found to be 48.9 %, 20.4 %, 6.2 % (Table 
1), and 27.5 % respectively. Three isolates 
of Klebsiella pneumoniae and 8 isolates of 
Escherichia coli showed coexistence of 
their phenotypes which showed a signifi-
cant correlation (p value <0.05) along with 
the production of ESBL. All the cefoxitin 
resistant isolates were AmpC β-lactamase 
among gram negative isolates, indicating 
that cefoxitin was a good drug for the de-
tection of AmpC β-lactamase. 
The maximum ESBL activity was seen 
in Escherichia coli (52.74 %), followed by 
P. aeruginosa (53.9 %) and Klebsiella 
pneumoniae (45.1 %). The maximum 
AmpC β-lactamase production was found in 
P. aeruginosa (34.7 %) followed by E. coli 
(19.8 %) and K. pneumoniae (18.2 %) and 
P. mirabilis (14.2 %).  
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Table 1: Prevalence of ESBL, AmpC β-lactamases and the coexistence of resistance (ESBL + AmpC 
β-lactamases) among gram negative bacilli in various clinical isolates 
 
Isolates ESBL 
(%) 
AmpC 
(%) 
ESBL + AmpC (%) 
Escherichia coli 48/91 
(52.8) 
18/91 
(19.8) 
8/91 
(8.8) 
Klebsiella pneumoniae 37/82 
(45.1) 
15/82 
(18.2) 
3/82 
(3.7) 
Pseudomonas aeruginosa 14/26 
(53.9) 
9/26 
(34.7) 
2/26 
(7.7) 
Proteus mirabilis 9/21 
(42.9) 
3/21 
(14.2) 
0/21 
(0) 
Enterobacter aerogenes 2/4 
(50) 
1/4 
(25) 
1/4 
(25) 
Total 110/225 
(48.9) 
46/225 
(20.4) 
14 
(6.2) 
 
 
Out of 58 oxacillin resistant isolates 42 
isolates were resistant to cefoxitin, which 
were further confirmed as MRSA strains by 
the oxacillin E-test (p <0.0001). Out of 42 
MRSA, 90.4 % MRSA isolates were from 
coagulase positive S. aureus whereas 
9.52 % MRSA isolates were from coagu-
lase negative S. aureus. 
Antibiogram patterns for the gram nega-
tive isolates analyzed showed ESBL-
producing isolates to possess a higher de-
gree of resistance towards antibiotics that 
are routinely prescribed against urinary 
tract infections as compared to non-ESBL-
producing isolates (Figure 1). Cephalospor-
in resistance was higher in ESBL producing 
(87-94 %) when compared to ESBL non 
producers. Combination of β-lactam/β-
lactamase inhibitors showed greater activity 
in both ESBL producers and non-producers. 
However, all isolates were sensitive to 
imipenam. Among aminoglycosides, re-
sistance to amikacin was found to be com-
paratively lower in both ESBL and non-
ESBL producers.  
 
   
Figure 1: Comparison of antibiotic resistance 
pattern in both ESBL producers and non-ESBL 
producers 
 
S. aureus were resistant to two to four-
teen antibiotics out of fifteen antibiotics 
tested corrsponding to a multiple antibiotic 
resistance index (MAR) range from 0.27 to 
0.93. Antibiotic sensitivity pattern in 
MRSA isolates revealed 92.9 % sensitivity 
for vancomycin, 81 % to amikacin and 
79 % for linezolid and teicoplanin. The 
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maximum resistance was seen against peni-
cillin, fusidic acid, cotrimoxazole, pristi-
nomycin, rifampicin and mupirocin 
(47.7 %) (Figure 2).  
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Figure 2: Antibiotic resistance pattern of other 
antibiotics in MRSA isolates 
 
DISCUSSION 
Knowledge on local antimicrobial re-
sistance trends among urinary isolates is 
important not only in guiding clinicians to 
prescribe appropriate antibiotics but also for 
evidence based recommendations in empir-
ical antibiotic treatment of UTI. The current 
study describes the antimicrobial resistance 
rates including detection of ESBL, AmpC 
β-lactamase and MRSA among urinary iso-
lates. 
The study revealed E. coli and Klebsiel-
la species to be the dominant organisms 
among other uropathogens. This result co-
incides with the previous report on the pre-
dominance of these pathogens (Karou et al., 
2009; Moyo et al., 2010). Some studies, 
however, have shown a decline of E. coli, 
being replaced by other members of the En-
terobacteriaceae. The UTIs are more fre-
quent in women than in men, principally 
owing to anatomic and physical factors 
(Muvunyi et al., 2011; Moyo et al., 2010).  
Antimicrobial susceptibility patterns of 
uropathogens vary widely by region. In the 
current study the antimicrobial resistance 
rate of gram negative isolates was high to 
the first line antimicrobial agents such as 
ampicillin, cotrimoxazole, and amoxicil-
lin/clavulanic acid. This may be due to 
wide use of these drugs empirically because 
they are relatively cheap and also by being 
oral antibiotics they are easy to administer. 
In India, the prevalence of ESBLs has 
been reported from 1990s. The occurrence 
of ESBL producers among the gram nega-
tive bacilli in the current study was 48.9 %. 
This number is less than that previously re-
ported (Dalela et al., 2012; Narayanaswamy 
and Mallika, 2011). The present study re-
ports 27.4 % MRSA among S. aureus iso-
lates. Few earlier studies have reported 
comparable prevalence of 24 % in Chandi-
garh (Mehta et al., 2007), 31.1 % in a mul-
ticenter study in Tamilnadu (Rajaduraipan-
di et al., 2006). In contrast, variable preva-
lence of 80.89 % in Indore (Verma et al., 
2000) and 54.9 % in eastern Uttar Pradesh 
(Anupurba et al., 2003) has also been re-
ported. This variability could be due to dif-
ference in the study design, population and 
geographical distribution and the variation 
is probably due to differential clonal expan-
sion and drug pressure in community. In the 
current study, 52.8 % and 45.1 % of E. coli 
and K. pneumoniae were identified as 
ESBL-producers. 
Recently, the co-existence of both 
AmpC β-lactamase and ESBL in some 
gram negative bacilli has also been report-
ed. This could be because plasmid mediated 
AmpC β-lactamase has been disseminated 
among the Enterobacteriaceae. These 
strains in combination with ESBL may give 
false negative tests in the detection of 
ESBL. 
ESBL-producing strains showed a sig-
nificantly high rate of resistance to non β- 
lactam antibiotics. These findings are simi-
lar to those reported by others (Ndugulile et 
al., 2005; Mehrgan and Arab-Halvaii, 
2010). This observation may be explained 
by the fact that ESBL are plasmid mediated 
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enzymes which are transferable between 
one bacterium to another and such transfer-
able plasmids also code for resistance de-
terminants to antimicrobial agents other 
than β-lactams (Paterson, 2006). 
Among the oral antibiotics, norfloxacin 
a commonly prescribed for the treatment of 
UTI in India and also in other countries 
(Karlowsky et al., 2003) showed a high re-
sistance rate against uropathogens in our 
study which indicated an increased quino-
lone resistance in our area, the findings are 
consistent with those of the previous studies 
(Akram et al., 2007; Manjunath et al., 
2011). Another oral antibiotic nitrofuranto-
in was found to be more effective in the 
treatment of UTI, these findings are in 
agreement with similar surveillance studies 
(Khameneh and Afshar, 2009). A low de-
gree of resistance to amikacin was observed 
for both ESBL and non-ESBL producers 
and hence may be helpful in combating se-
vere infections. In our study, imipenem was 
the only drug found unaffected by the ac-
tion of these enzymes. These findings are in 
concordance with the studies conducted by 
other authors, who also reported a rate of 
100 % sensitivity to imipenam (Sasirekha 
and Srividya, 2012). 
The current study, which examines the 
spread of drug resistance among uropatho-
gens, is perhaps first of its kind as it is not 
restricted to a specific health care center. 
On the basis of our findings, we suggest 
urine culture and antimicrobial susceptibil-
ity testing for UTI patients. Continuous 
analysis of the antibiotic resistance pattern 
acts as a guide in initiating the empirical 
treatment of UTI. Development of regional 
surveillance programs is necessary to pro-
vide information which would then enable 
the development of Indian UTI guidelines. 
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